Solaymani-Dodaran, M., Ghanei, M., Bagheri, M., Qazvini, A., Vahedi, E., Hassan Saadat, S., . . . Moazen, J. (2021). Safety and efficacy of Favipiravir in moderate to severe SARS-CoV-2 pneumonia. Int Immunopharmacol.
シカゴスタイル引用形Solaymani-Dodaran, Masoud, et al. "Safety and Efficacy of Favipiravir in Moderate to Severe SARS-CoV-2 Pneumonia." Int Immunopharmacol 2021.
MLA引用形式Solaymani-Dodaran, Masoud, et al. "Safety and Efficacy of Favipiravir in Moderate to Severe SARS-CoV-2 Pneumonia." Int Immunopharmacol 2021.
警告: この引用は必ずしも正確ではありません.